(Q80279663)
English
A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mi
scientific article published on 27 April 2007
Statements
A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mitomycin C (English)
Antonio Ojea
José Luís Nogueira
Eduardo Solsona
Nicolás Flores
Jesús María Fernández Gómez
Jesús Rodríguez Molina
Venancio Chantada
José Emilio Camacho
Luís Martínez Piñeiro
Rafael Hernandez Rodríguez
Santiago Isorna
Miguel Blas
José A Martínez-Piñeiro
Rosario Madero
CUETO Group (Club Urológico Español De Tratamiento Oncológico)
27 April 2007